Psychotherapy for Psychosis, Adverse Events, and Substance Misuse
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Psychotic Disorders
- Schizophrenia
- Stress Disorders, Traumatic
- Substance Related Disorders
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: A single-case experimental design (SCED), specifically, a multiple-baseline design (MBD) [1] will be used; the MBD temporally staggers intervention start times across participants, thereby creating a control group composed of each individual's pre-intervention scores. Randomization of each participant's treatment start time will be used to increase internal validity and minimize bias [2],[3]. Participants will be randomized using a random sampling/assignment generator (randomizer.org). An MBD is most appropriate for a study focused on the optimization of PE+ as it will allow a fine-grained assessment of what components have more or less effectiveness in EPP. This design can also detect significant change during each phase of the intervention. In order to meet standards of evidence for SCEDs, this study will include a total of five treatment phases, which exceeds the recommended minimum of three phases [4].Masking: Single (Outcomes Assessor)Masking Description: The research assistant or therapist conducting the symptom assessments will not have access to information regarding that participant's treatment, and the person providing the treatment will not have access to the information regarding assessments of that participant's symptoms. Therapists will only conduct a symptom assessment for participants that are working with another therapist; they may not conduct a symptom assessment for participants with whom they are working through the intervention.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 19 years and 35 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04546178
- Collaborators
- Queen Elizabeth II Health Sciences Centre Foundation
- Research Nova Scotia
- Killam Laureates
- Investigators
- Principal Investigator: Victoria Patterson, PhD student Dalhousie University
Get Well Soon